|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| C07K 16/30 | |||
| A61K 39/395 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2976360 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14714586.6 |
| Europos patento paraiškos padavimo data | 2014-03-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-01-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-11-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2014/000719 |
| Data | 2014-03-17 |
| (87) | Numeris | WO 2014/146778 |
| Data | 2014-09-25 |
| (30) | Numeris | Data | Šalis |
| PCT/EP2013/0008 | 2013-03-18 | WO |
| (72) |
SAHIN, Ugur, DE
TÜRECI, Özlem, DE
|
| (73) |
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige Gmb,
Freiligrathstrasse 12, 55131 Mainz,
DE
Astellas Pharma Inc., 5-1, Nihonbashi-Honcho 2-Chome, Chuo-ku Tokyo 103-8411, JP |
| (54) | THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER |
| THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER |